Parataxis Holdings LLC Announces Definitive Agreement with Bridge Biotherapeutics, Inc. (KOSDAQ: 288330), to Bring Institutionally-Backed, Bitcoin Treasury Company to the South Korean Public Markets:
Submitted by Anonymous (not verified) on Fri, 06/20/2025 - 15:10
PRNewswire, PRNewswire, 20th June 2025, Chainwire